Proficio Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.7M Buy
7,281
+10
+0.1% +$10.1K 0.36% 49
2025
Q4
$7.81M Sell
7,271
-2,020
-22% -$1.93M 0.55% 37
2025
Q3
$7.09M Sell
9,291
-7,515
-45% -$5.59M 0.49% 37
2025
Q2
$13.1M Sell
16,806
-1,435
-8% -$1.12M 0.81% 29
2025
Q1
$15.1M Buy
18,241
+11,502
+171% +$9.57M 1.16% 18
2024
Q4
$5.2M Buy
6,739
+1,562
+30% +$1.29M 0.42% 43
2024
Q3
$4.59M Sell
5,177
-1,405
-21% -$1.26M 0.46% 40
2024
Q2
$5.96M Buy
6,582
+71
+1% +$56.8K 0.63% 27
2024
Q1
$5.06M Buy
6,511
+106
+2% +$75.4K 0.56% 38
2023
Q4
$3.73M Sell
6,405
-32
-0.5% -$18.7K 0.46% 37
2023
Q3
$3.46M Buy
6,437
+172
+3% +$88.6K 0.46% 37
2023
Q2
$2.94M Buy
6,265
+62
+1% +$26K 0.4% 42
2023
Q1
$2.13M Buy
6,203
+3,075
+98% +$1.04M 0.34% 48
2022
Q4
$1.14M Buy
3,128
+26
+0.8% +$9.22K 0.22% 66
2022
Q3
$1M Buy
3,102
+68
+2% +$21.5K 0.18% 77
2022
Q2
$984K Buy
3,034
+225
+8% +$67.5K 0.18% 76
2022
Q1
$804K Sell
2,809
-283
-9% -$72.8K 0.12% 91
2021
Q4
$854K Buy
3,092
+49
+2% +$12.4K 0.12% 104
2021
Q3
$703K Sell
3,043
-65
-2% -$16K 0.09% 116
2021
Q2
$713K Sell
3,108
-51
-2% -$10.2K 0.09% 110
2021
Q1
$590K Buy
3,159
+1,099
+53% +$215K 0.08% 117
2020
Q4
$348K Sell
2,060
-571
-22% -$85.3K 0.05% 124
2020
Q3
$335K Buy
2,631
+296
+13% +$45.8K 0.06% 118
2020
Q2
$383K Buy
2,335
+340
+17% +$52.2K 0.08% 105
2020
Q1
$318K Buy
+1,995
New +$274K 0.08% 105
2019
Q3
Sell
-1,346
Closed -$149K 909
2019
Q2
$149K Sell
1,346
-451
-25% -$53.1K 0.05% 164
2019
Q1
$233K Buy
1,797
+670
+59% +$81.5K 0.08% 118
2018
Q4
$130K Buy
1,127
+541
+92% +$60.4K 0.06% 143
2018
Q3
$63K Buy
586
+26
+5% +$2.6K 0.02% 295
2018
Q2
$48K Buy
560
+72
+15% +$5.91K 0.02% 368
2018
Q1
$38K Sell
488
-279
-36% -$22.5K 0.01% 421
2017
Q4
$65K Buy
767
+46
+6% +$3.91K 0.02% 291
2017
Q3
$62K Buy
721
+254
+54% +$20.8K 0.03% 334
2017
Q2
$38K Sell
467
-126
-21% -$10.3K 0.02% 447
2017
Q1
$46K Buy
593
+355
+149% +$28.4K 0.02% 405
2016
Q4
$18K Sell
238
-101
-30% -$7.52K 0.01% 481
2016
Q3
$27K Hold
339
0.02% 376
2016
Q2
$28K Buy
339
+231
+214% +$17.4K 0.02% 371
2016
Q1
$8K Sell
108
-162
-60% -$12.3K 0.01% 437
2015
Q4
$23K Buy
+270
New +$22.4K 0.02% 177

Other funds holding LLY

Proficio Capital Partners's LLY Position: Q1 2026 in Review

Proficio Capital Partners increased its Eli Lilly (LLY) stake by 0.14% in Q1 2026, buying an estimated $10.1K and bringing the position to 7,281 shares worth $6.7M. The position accounts for 0.36% of the portfolio, ranked #49.

Proficio Capital Partners first reported a position in LLY in Q4 2015 and has held it in 40 quarters since. The position peaked at $15.1M in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Proficio Capital Partners held 7,281 shares of Eli Lilly worth $6.7M as of Q1 2026.
  • Proficio Capital Partners bought 10 Eli Lilly shares in Q1 2026, an estimated $10.1K.
  • Eli Lilly made up 0.36% of Proficio Capital Partners's portfolio in Q1 2026, its #49 holding.
  • Proficio Capital Partners first reported a position in Eli Lilly in Q4 2015 and has held it in 40 quarters since.
  • Proficio Capital Partners's Eli Lilly position peaked at $15.1M in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Proficio Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.